ABSTRACTS SEARCH
Search results
- Pinolenic acid co-activates free fatty acid receptors 1 and 4 and this signalling reduces GPR119 agonism in mouse colon mucosa R. Moodaley1, M. Schindler2, D. M. Smith3, H. M. Cox1. 1Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom, 2Innovative Medicines & Early Development, Cardiovascular & Metabolic Diseases iMed, AstraZeneca M”lndal, M”lndal, Sweden, 3Discovery Sciences, Innovative Medicines & Early Development Biotech Unit, AstraZeneca, Cambridge, United Kingdom
- Pioglitazone Versus Metformin In The Treatment Of Obese Patients With Concomitant Polycystic Ovarian Syndrome And Major Depressive Disorder: A Double Blind, Randomized Clinical Trial Akhondzadeh S, Kashani L
- Piracetam added to risperidone in patients with autistic disorder: A double- blind placebo controlled trial. Shahin Akhondzadeh; Hamid Tajdar; Mohammad-Reza Mohammadi; Ladan Kashani
- PKA and Epac activation counteract hypoxia-induced NO/ROS imbalance in human coronary artery endothelial cells Garcia Morales V, Krenning G, Dekker F, Maarsingh H, Campos Toimil M, Schmidt M
- PKA-dependent Akt/nNOS pathway mediates baroreflex enhancement by adrenomedullin in the nucleus tractus solitarii of rats Yen JC, Chiu YC, Li FCH, Chang AYW
- PK and PD of a Nicotinic Anti-Cholinergic Challenge with Mecamylamine and Comparison to Scopolamine AC Baakman, R Rissmann, E Klaassen, JMA van Gerven, GJ Groeneveld
- PKC inhibition differentially affects ERK activation by µ opioid receptor agonists E Tsisanova, G Henderson, E Kelly
- PKC inhibition differentially affects ERK activation by µ opioid receptor agonists E Tsisanova, G Henderson, E Kelly
- ®" in Healthy Human Subjects" >PK/PD and Safety Evaluation of 20kDa Peginterferon α-2a from "Unipeg®" in Healthy Human Subjects Ahmad T
- Plasma adypokines in a Venezuelan population with newly diagnosed metabolic syndrome. Mathison Y, Sanchez L, Lopez Y, Figueira L, Garrido MR, Israel A